All In Biotech

Free tool

FAERS Monitor: Xalatan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020597 or its brand name (Xalatan, Latanoprost). Reports on generic versions are filed under their own applications.

Reports

50,175

Serious

27,826

55% of reports

Hospitalization

10,574

Death reported

3,136

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure5,934
  • drug ineffective3,267
  • fatigue2,378
  • eye irritation2,178
  • headache1,837
  • intraocular pressure increased1,787
  • dyspnoea1,678
  • diarrhoea1,676
  • dizziness1,655
  • off label use1,647
  • eye pain1,642
  • death1,620
  • nausea1,597
  • vision blurred1,520
  • fall1,460

Reports by year received

View as table
YearReports
2004427
2005616
2006656
2007703
2008719
2009834
20102,052
20111,687
20121,971
20131,643
20141,876
20152,271
20162,722
20172,570
20182,846
20193,051
20208,873
20212,408
20222,369
20232,431
20242,481
20252,766
20262,203

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,984 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal1,78768.064.7101,446
treatment failureSignal5,93432.331.5167,532
eye irritationSignal2,17816.415.830,470
eye painSignal1,64212.511.916,957
vision blurredSignal1,5204.74.54,376
fall1,4601.81.8568
dizziness1,6551.41.3186
fatigue2,3781.31.2152
dyspnoea1,6781.21.282
headache1,8371.21.280
diarrhoea1,6761.11.012
drug ineffective3,2671.01.05
nausea1,5970.80.847
off label use1,6470.80.898
death1,6200.80.896

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.